Revenues, Recognition and Allowances (Tables)

3 Months Ended

Mar. 31, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenues

Net revenues for the three months ended March 31, 2020 and 2019 were as follows:

	Three months ended March 31,
	2020		2019
Company product sales	$	7,139	$	12,495
Contract manufacturing sales	197		542
Research and development services and other income	$	111	$	85
Revenue, net	$	7,447	$	13,122

Disaggregated information for the Company product sales revenue has been recognized in the accompanying unaudited interim Condensed Consolidated Statements of Operations and is presented below according to contract type:

	Three months ended March 31,
Company Product Sales	2020		2019
Topical	$	5,380	$	9,032
Injectables	1,759		3,463
Total	$	7,139	$	12,495

Schedule of Accounts, Notes, Loans and Financing Receivable

The Company's adjustments for the deductions to gross product sales are as follows:

	Three months ended March 31,
	2020		2019
Gross product sales	$	23,166	$	27,414
Deduction to gross product sales:
Chargebacks and billbacks	11,955		10,886
Wholesaler fees for service	1,142		1,766
Sales discounts and other allowances	2,930		2,267
Total reduction to gross product sales	$	16,027	$	14,919
Company product sales, net	$	7,139	$	12,495